Your search returned 12 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. 342P QOL analysis of a phase II randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel as second line or above therapy in recurrent head and neck cancer

by Chanana R | Noronha V | Joshi A | Patil V | Dhumal S | Bhattacharya A | Chandrasekharan A | Pande N | Talreja VT | Turkar S | Shrirangwar S | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

2. Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer

by Ostwal V | Bose S | Sirohi B | Poladia B | Sahu A | Bhargava P | Doshi V | Dusane R | Nashikkar C | Shrikhande SV | Ramaswamy A [Corresponding author].

In Indian Journal of Cancer
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

3. Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer

by Oh, S. C | Choi, I. K | Park, K. H | .

In British Journal of Cancer
Material type: article Article; Format: print Publisher: 2005Availability: Items available for loan: Tata Memorial Hospital [Call number: Oh,/Par] (1).

4. High pathologic complete remission rate from induction docetaxel, platinum and fluorouracil (DCF) combination chemotherapy for locally advanced esophageal and junctional cancer

by Noronha V | Jambhekar N | Jandyal S | Joshi A | kprabhash1@gmail.com | Prabhash K.

In Medical Oncology
Material type: article Article; Format: print Publisher: 2014Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

5. Localized prostate cancer: can we better define who is at risk of unfavourable outcome?

by Poppel HV | Steven.Joniau@uzleuven.be | Joniau S.

In British Journal of Urology
Material type: article Article; Format: print Publisher: 2008Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

6. Management of metastatic prostate cancer: the crucial role of geriatric assessment

by Chaladaj A | jpdroz@orange.fr | Droz JP.

In British Journal of Urology
Material type: article Article; Format: print Publisher: 2008Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

7. Modified, weekly dosing with docetaxel and cisplatin as first-line therapy in advanced non-small cell lung cancer

by Hsiao Shih-Chuan | Su Wu-Chou | sunnysu@mail.ncku.edu.tw.

In The National Medical Journal of India
Material type: article Article; Format: print Publisher: 2009Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

8. Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter randomized open-label Phase II study

by Babu KG | Mohan R | Raina V | Goswami C | Nag S | Malhotra H | Kar M | Rao R | Diwakar RB | Sirohi B | Vaid AK | Prabhash K | .

In Onco Targets and Therapy
Material type: article Article; Format: print Publisher: 2014Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

9. Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer

by Joshi A | Patil V | Noronha V | Dhumal S | Pande N | Chandrasekharan A | Turkar S | DSouza H | Shrirangwar S | Mahajan A | Arya S | Juvekar S | BhattaCharjee A | Prabhash K [Corresponding author].

In Oral Oncology.
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

10. Rhabdoid variant of lung cancer: Clinicopathological details of a case and a review of literature

by Rath GK | Sharma M | Puri T | Julka PK | Kumar M | drgagansaini@gmail.com | Saini G.

In Journal of Cancer Research and Therapeutics
Material type: article Article; Format: print Publisher: 2009Availability: Items available for loan: Tata Memorial Hospital [Call number: ] (1).

11. Toxicity and Tolerance of Concurrent Docetaxel with Radiotherapy in Cisplatin Ineligible Head and Neck Cancer Patients.

by Simha V | Patil V | Noronha V | Talreja V | Dhumal S | Chandrasekharan A | Shrirangwar S | Prabhash K.

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

12. Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

by Paz-Ares LG [Corresponding author] | Pérol M | Ciuleanu TE | Kowalyszyn RD | Reck M | Lewanski CR | Syrigos K | Arrieta O | Prabhash K | Park K | Pikiel J | Göksel T | Lee P | Zimmermann A | Carter GC | Alexandris E | Garon EB.

In Lung Cancer
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha